跳至主要内容
临床试验/IRCT20180818040827N5
IRCT20180818040827N5尚未招募3 期

The effect of zinc supplementation separately and in combination with probiotics on inflammatory and oxidative stress indicators, the severity of gastrointestinal symptoms, mood disorders, quality of life and sleep in patients with irritable bowel syndrome: a double-blind randomized controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Patients who agree to participate in the study.
  • Diagnosis of IBS by a gastroenterologist based on the Rome IV criteria
  • Body mass index between 18.5 to 40

排除标准

  • Regular consumption of probiotics and prebiotics products and supplements at least 2 months before the start of the study
  • Taking zinc supplement in the last 6 months or following a special diet
  • History of gastrointestinal surgery, celiac disease, infection or cancer of the gastrointestinal tract, inflammatory bowel diseases, rheumatism and other inflammatory diseases and malignancy
  • Pregnant, breastfed, or hospitalized
  • Allergy to the ingredients in the supplement
  • Drinking alcohol, smoking
  • Penicillamine use, regular use of anti-diarrheal or laxative drugs, antibiotics, use of drugs that alter digestive movements, use of drugs that increase bleeding from intestinal mucus such as warfarin, heparin
  • Professional athletes
  • All types of anemia

研究者

相似试验